Previous Article | Next Article ![]()
J Virol, February 1998, p. 1262-1269, Vol. 72, No. 2
Departments of
Immunology1 and
Neurology,2 Mayo Clinic, Rochester,
Minnesota 55905, and
Department of Neurology, University of
Chicago Medical Center, Chicago, Illinois 606373
Received 10 June 1997/Accepted 16 October 1997
Wild-type Daniel's strain of Theiler's virus (wt-DA) induces a
chronic demyelination in susceptible mice which is similar to multiple
sclerosis. A variant of wt-DA (designated DA-P12) generated during the
12th passage of persistent infection of a G26-20 glioma cell line
failed to persist and induce demyelination in SJL/J mice. To identify
the determinants responsible for this change in phenotype, we sequenced
the capsid coding sequence (nucleotides [nt] 2991 to 3994) and found
three mutations in VP1: residues 99 (Gly to Ser), 100 (Gly to Asp), and
103 (Asn to Lys). To study the role of these mutations in
neurovirulence and demyelination, we prepared a recombinant virus,
DAP-1C-2A/DA, with replacement of wt-DA nt 2991 to 3994 with the
corresponding region of DA-P12, and viruses with individual point
mutations at VP1 residues 99(Ser), 100(Asp), and 103(Lys). DAP-1C-2A/DA
and viruses with a mutation at VP1 residue 99 or 100 (but not 103)
completely attenuated the ability of wt-DA to induce demyelination.
Failure to induce demyelination was not due to a general failure in
growth, since DA-P12 and other mutant viruses lysed L-2 cells in vitro
as effectively as wt-DA. The change in disease phenotype was
independent of the specific B- or T-cell immune recognition because a
decrease in the neurovirulence of mutant viruses was observed in
neonatal mice and immune-deficient RAG1
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Molecular Characterization of a Nondemyelinating
Variant of Daniel's Strain of Theiler's Virus Isolated from a
Persistently Infected Glioma Cell Line

/
mice. This difference in
neurovirulence is not the complete explanation for the failure of
DA-P12 to demyelinate, since virus with a mutation at residue 103(Lys)
had decreased neurovirulence but did induce demyelination. Therefore,
point mutation at VP1 residue 99 or 100 altered the ability of wt-DA to
demyelinate, perhaps related to a disruption in interaction between
virus and receptor on certain neural cells.
*
Corresponding author. Mailing address: Departments of
Neurology and Immunology, Mayo Clinic, 200 First St., S.W., Rochester, MN 55905. Phone: (507) 284-5365. Fax: (507) 284-1637. E-mail: rodriguez{at}rcf.mayo.edu.
Present address: Agouron Pharmaceuticals, Inc., San Diego, CA
92121.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»